Quarterly report pursuant to Section 13 or 15(d)

Restatement of Previously Issued Financial Statements (Tables)

v3.24.3
Restatement of Previously Issued Financial Statements (Tables)
3 Months Ended
Jul. 31, 2024
Accounting Changes and Error Corrections [Abstract]  
Restatement tables

Restatement tables

CONDENSED CONSOLIDATED BALANCE SHEETS   July 31, 2023
As Reported
    Adjustment     July 31, 2023
As Restated
 
Convertible Preferred Stock:
Series B convertible preferred stock: authorized 35,000 shares, $0.0001 par value and $1,000 face value, 35,000 and 0 shares issued and outstanding as of July 31, 2023 and April 30, 2023, respectively. Liquidation Preference of $35,000,000 plus dividends accrued at 4% per annum of $319,849 and $0, as of July 31, 2023 and April 30, 2023, respectively.
  $ 16,753,075     $ 3,272,033     $ 20,025,108  
Additional paid-in capital     202,230,646       (3,591,882 )     198,638,764  
Accumulated deficit     (119,461,919 )     319,849       (119,142,070 )
Treasury stock     (40,017,947 )     (264,573 )     (40,282,520 )
Total stockholders' equity     42,730,395       (3,536,606 )     39,193,789  
Total Liabilities, Convertible Preferred Stock and Stockholders' Equity     79,880,485             79,880,485  

 

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS   July 31, 2023
As Reported
    Adjustment     July 31, 2023
As Restated
 
Preferred stock accretion   $     $ (3,272,033 )   $ (3,272,033 )
Net income (loss) attributable to common stockholders     (3,503,146 )     (3,272,033 )     (6,775,179 )
Net loss per share, basic and diluted   $ (0.28 )   $ (0.26 )   $ (0.54 )

 

CONDENSED CONSOLIDATED STATEMENTS OF CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS’ EQUITY   July 31, 2023
As Reported
    Adjustment     July 31, 2023
As Restated
 
Preferred Stock (Amount)   $ 16,753,075     $ 3,272,033     $ 20,025,108  
Additional paid-in capital     202,230,646       (3,591,882 )     198,638,764  
Accumulated deficit     (119,461,919 )     319,849       (119,142,070 )
Treasury stock     (40,017,947 )     (264,573 )     (40,282,520 )
Total Stockholders' Equity Balance, July 31, 2023     42,730,395       (3,536,606 )     39,193,789  

 

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS   July 31, 2023
As Reported
    Adjustment     July 31, 2023
As Restated
 
Supplemental disclosure of cash flows information                        
Accretion of discounts to redemption value of Series B Preferred Stock   $     $ 3,272,033     $ 3,272,033